Page last updated: 2024-09-04

buddlejasaponin iv and Carcinoma, Epidermoid

buddlejasaponin iv has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, WY; Hwang, YS; Kim, EC; Kim, J; Park, HJ; Park, KK1

Other Studies

1 other study(ies) available for buddlejasaponin iv and Carcinoma, Epidermoid

ArticleYear
Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes.
    Phytotherapy research : PTR, 2011, Volume: 25, Issue:10

    Topics: Alphapapillomavirus; Antineoplastic Agents, Phytogenic; Apiaceae; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Humans; Keratinocytes; Mitochondria; Mouth Mucosa; Mouth Neoplasms; Nuclear Proteins; Phosphorylation; Phytotherapy; Plant Extracts; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Salivary Proline-Rich Proteins; Saponins; Triterpenes; Tumor Necrosis Factors; Tumor Protein p73; Tumor Suppressor Proteins

2011